Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q2 2024 Earnings Call Transcript August 1, 2024

Vertex Pharmaceuticals Incorporated misses on earnings expectations. Reported EPS is $-12.83 EPS, expectations were $-11.63.

Operator: Good day! And welcome to the Vertex Pharmaceuticals Second Quarter 2024 Earnings Conference Call. All participants will be in a listen only mode. [Operator Instructions]. After today’s presentation, there will be an opportunity to ask questions. Please note this...